BMD4503-1
BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 301357-76-6
- Fòrmula: C22H19N5O3S
- Peso molecular:433.48
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
No. CAS 301357-76-6
-
Peso molecular 433.48
-
Fòrmula C22H19N5O3S
-
SMILES
O=C(C)NC1=CC=C(S(=O)(NC2=NC3=C(N=C2NC4=CC=CC=C4)C=CC=C3)=O)C=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)